http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1329933-C
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7c22980d25eb1d159f269bf4aa2c03c |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-22 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-56 |
filingDate | 1987-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1994-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3090163ed2ad0e744dfb694fee55617 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdf483a55003e3da6f2136923d1c7f08 |
publicationDate | 1994-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-1329933-C |
titleOfInvention | Carboxamide derivatives |
abstract | ABSTRACT "Carboxamide Derivatives" This invention provides a series of novel heterocyclic carboxamides of Formula I I in which the group -Y-Z< is selected from -C(Ra)=C<, -N=C<, and -CH(Ra)-CH< and the other radicals have the meanings defined in the following specification. The compounds of Formula I are leukotriene antagonists. The invention also provides pharmaceutically acceptable salts of the Formula I compounds; pharmaceutical compositions containing the Formula I compound, or their salts, for use in the treatment of, for example, allergic or inflammatory diseases, or endotoxic or traumatic shock conditions; and processes for the manufacture of the Formula I compounds, as well as intermediates for use in such manufacture. |
priorityDate | 1986-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 292.